Literature DB >> 10628835

NIH 3T3 cells malignantly transformed by mot-2 show inactivation and cytoplasmic sequestration of the p53 protein.

R Wadhwa1, S Takano, Y Mitsui, S C Kaul.   

Abstract

In previous studies we have reported that a high level of expression of mot-2 protein results in malignant transformation of NIH 3T3 cells as analyzed by anchorage independent growth and nude mice assays [Kaul et al., Oncogene, 17, 907-11, 1998]. Mot-2 was found to interact with tumor suppressor protein p53. The transient overexpression of mot-2 was inhibitory to transcriptional activation function of p53 [Wadhwa et al., J. Biol. Chem., 273, 29586-91, 1998]. We demonstrate here that mot-2 transfected stable clone of NIH 3T3 that showed malignant properties indeed show inactivation of p53 function as assayed by exogenous p53 dependent reporter. The expression level of p53 in response to UV-irradiation was lower in NIH 3T3/mot-2 as compared to NIH 3T3 cells and also exhibited delay in reaching peak. Furthermore, upon serum starvation p53 was seen to translocate to the nucleus in NIH 3T3, but not in its mot-2 derivative. The data suggests that mot-2 mediated cytoplasmic sequestration and inactivation of p53 may operate, at least in part, for malignant phenotype of NIH 3T3/mot-2 cells. NIH 3T3/mot-2 cells show inactivation of p53 protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10628835     DOI: 10.1038/sj.cr.7290025

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  14 in total

Review 1.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?

Authors:  Renu Wadhwa; Kazunari Taira; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

2.  2- and N6-functionalized adenosine-5'-diphosphate analogs for the inhibition of mortalin.

Authors:  Mitchell A Moseng; Jay C Nix; Richard C Page
Journal:  FEBS Lett       Date:  2019-06-18       Impact factor: 4.124

3.  Crystal structure of the nucleotide-binding domain of mortalin, the mitochondrial Hsp70 chaperone.

Authors:  Joseph Amick; Simon E Schlanger; Christine Wachnowsky; Mitchell A Moseng; Corey C Emerson; Michelle Dare; Wen-I Luo; Sujay S Ithychanda; Jay C Nix; J A Cowan; Richard C Page; Saurav Misra
Journal:  Protein Sci       Date:  2014-04-17       Impact factor: 6.725

Review 4.  Chaperones in cell cycle regulation and mitogenic signal transduction: a review.

Authors:  K Helmbrecht; E Zeise; L Rensing
Journal:  Cell Prolif       Date:  2000-12       Impact factor: 6.831

5.  Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2.

Authors:  S Sengupta; B Wasylyk
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

Review 6.  Intracellular monovalent ions as second messengers.

Authors:  S N Orlov; P Hamet
Journal:  J Membr Biol       Date:  2006-08-14       Impact factor: 1.843

Review 7.  Strategies for manipulating the p53 pathway in the treatment of human cancer.

Authors:  T R Hupp; D P Lane; K L Ball
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

8.  [Isolation of mitochondrial DNA binding proteins which are specific for maize cox1 promoter].

Authors:  V I Tarasenko; I Iu Subota; V F Kobzev; Iu M Konstantinov
Journal:  Mol Biol (Mosk)       Date:  2005 May-Jun

Review 9.  Molecular chaperones regulate p53 and suppress senescence programs.

Authors:  Michael Y Sherman; Michael Sherman; Vladimir Gabai; Cornelia O'Callaghan; Julia Yaglom
Journal:  FEBS Lett       Date:  2007-05-25       Impact factor: 4.124

Review 10.  Allostery in the Hsp70 chaperone proteins.

Authors:  Erik R P Zuiderweg; Eric B Bertelsen; Aikaterini Rousaki; Matthias P Mayer; Jason E Gestwicki; Atta Ahmad
Journal:  Top Curr Chem       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.